Whalegun
Home

Ultragenyx Pharmaceutical RARE paid Mehlman Consulting $60K for lobbying in Q1 2025 · Health Issues

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q1 2025
Stock
Ultragenyx Pharmaceutical RARE
Client
Ultragenyx Pharmaceutical
Reported
25/04/17

Up 20.0% from last quarter

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Ultragenyx Pharmaceutical's other lobbying reports